Please login to the form below

Not currently logged in
Email:
Password:

US government

This page shows the latest US government news and features for those working in and with pharma, biotech and healthcare.

Voice biomarker device could diagnose depression, heart disease

Voice biomarker device could diagnose depression, heart disease

That’s the promise of Sonde Health, a US-based company, which has just raised $16m in a series A financing round to fund the technology’s development. ... The tool was developed with funding from the US government health agencies, and uses AI to

Latest news

  • FDA starts review of Biogen’s Tecfidera follow-up for MS FDA starts review of Biogen’s Tecfidera follow-up for MS

    It was initally submitted towards the end of 2018 but had been delayed by US gov shutdown. ... BIIB098 (diroximel fumarate) was actually submitted for approval in the US towards the end of 2018 but appears to have been caught up in the US government

  • ‘Inflexible’ NICE blocking access to rare disease drugs ‘Inflexible’ NICE blocking access to rare disease drugs

    methods. That’s the conclusion of a report published by market access consultancy MAP BioPharma (MAP) which is urging England’s cost effectiveness watchdog to work with NHS England, the government ... MAP’s research illustrates that the current

  • Alector kicks off next wave of biotech IPOs Alector kicks off next wave of biotech IPOs

    US biotech raising money again. The US government shutdown of 35 days had deterred new IPOs in biotech, but market launches have now resumed with immune-neurology specialists Alector. ... Its plans had also been disrupted by the government shutdown, but

  • Rising economic risk casts shadow on Davos meeting Rising economic risk casts shadow on Davos meeting

    government shutdown is also pouring cold water on the economy, says the IMF. ... That list includes US president Donald Trump who said the government shutdown prevented him and the entire US delegation from attending, as well as UK prime minister Theresa

  • FDA expecting boom in cell and gene therapies FDA expecting boom in cell and gene therapies

    by the US government shutdown, now in its fourth week. ... The last couple of years have already seen the approval of the first gene therapy in the US – Spark Therapeutics’ Luxturna for a rare disease – as well as new cell therapies

More from news
Approximately 3 fully matching, plus 188 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    However the company, like many others, is at the mercy of the US government shutdown, which means many FDA staff are on unpaid leave, and threatens drug approval timelines if it ... Its early US take-up is encouraging, according to Shire, with Q3 sales

  • China’s clinical trial shake-up China’s clinical trial shake-up

    In 2007, 1% of trials registered on US government portal ClinicalTrials. ... Perhaps most importantly, China has moved to a US-style clinical trial application (CTA) system that guarantees sponsors will wait no more than 60 days to learn whether they can

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    By January 2018, the US Centers for Disease Control and Prevention had reported 29 cases of MCR resistance identified across 15 states of the USA. ... Alongside this, there have been equally important initiatives by the World Health Organization (WHO),

  • US health reforms US health reforms

    Meanwhile, the global industry waits with bated breath upon a recently elected, mercurial US federal government that whipsaws from one extreme to the other, sometimes within the hour. ... is a freelance writer based in the Philadelphia metro area of the

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    The only ‘fact’ is that ‘Brexit means Brexit’… so the Government tell us. ... Two post-referendum announcements have boosted the UK Government. GSK announced a £275 million investment in its UK manufacturing sites and Alnylam, a US biotech

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

  • Portland Health appoints Alfred Jackson as a partner Portland Health appoints Alfred Jackson as a partner

    In addition to his work in healthcare, Jackson also has broad experience in public affairs and government relations. ... agency experience, senior leadership and strategic relationships across the health and government sectors to deepen our offering to

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    He becomes government affairs and policy, Americas VP. Astellas has appointed Joseph Devaney as vice president of government affairs and policy for its Americas business. ... In this role, Devaney will be responsible for developing, communicating and

  • Pfizer’s CMO joins board of Tenet Pfizer’s CMO joins board of Tenet

    Freda Lewis-Hall to advise healthcare services firm. US healthcare services company Tenet Health Corporation has added pharma experience to its board with the appointment of Pfizer's chief medical officer ... In addition to her role at Pfizer Dr

  • Sanofi appoints NIH’s Gary Nabel as chief scientific officer Sanofi appoints NIH’s Gary Nabel as chief scientific officer

    He previously headed vaccine research centre of the US National Institute of Allergy and Infectious Diseases. ... Dr Nabel leaves the NIH, which is part of the US government's department of health, after 13 years as director of the vaccine research

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Genetic counsellors: the new healthcare influencers?

    The US government will cover the costs, signalling their commitment to more precise treatment that will drive better outcomes for patients across the U.S. ... There are more than  70, 000  different genetic testing products available on the US market

  • To track disease, follow the money

    of US banknotes, which are carried and passed on by people in the same way as disease. ... Lower-denomination banknotes are more likely to be contaminated (perhaps because they are more widely handled).(7)  A US government survey found that that 94% of

  • Could hackers threaten your health?

    In this year’s Def Con hacking conference, representatives from the US FDA, the government body responsible for the security of medical devices, spoke for the first time. Attempting to spark

  • Focus on Rare Diseases

    The US government passed the Orphan Drug Act in 1983, and it was subsequently adopted in other key markets, most notably in Japan in 1993 and the European Union in 2000.

  • Packer Forbes News January 2016

    She is a graduate in Politics and Parliamentary Studies from the University of Leeds, where she gained first-hand insight into the UK and US government health systems during her placement

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics